undefined
EUTM file information

018426442

InCerebro


March 11, 2021

Trademark Summary

The trademark application inCerebro was filed by InCerebro Co., Ltd., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on May 12, 2021, and it was registered by office on August 19, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and professional address of the trademark registration was recorded on February 1, 2022.


Goods And Services

  • The mark was filed in class 42 with following description of goods:
    1. Drug discovery services
    2. Conducting early evaluations in the field of new pharmaceuticals
    3. Research relating to pharmaceuticals
    4. Pharmaceutical research services
    5. Drug development
    6. Pharmaceutical drug development services
    7. Inspection of pharmaceuticals
    8. Pharmaceutical products evaluation
    9. Clinical testing of medicines
    10. Services for assessing the efficiency of pharmaceuticals
    11. Scientific research in the fields of medicine/health and pharmacology
    12. Analysis and evaluation of medical product development
    13. Platform as a Service [PaaS] for drug discovery
    14. Software as a service relating to computing drug discovery
    15. Development of computer platforms for computing drug discovery
    16. Working on and evaluation of chemical syntheses
    17. Medical research laboratory services
    18. Computer programming in the medical field
    19. Molecular analysis
    20. Computerised analysis of data relating to medical and pharmacological research and development
    21. Computerised analysis of data relating to pharmaceuticals products research and development
    22. Computerised analysis of data in the field of technological research
    23. Computerised analysis of data relating to scientific research and development
    24. Computerised analysis of data relating to computer-aided drug design
    25. Computerised analysis of data relating to scientific research information and results.